BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Aug 12, 2013
Clinical News

Teplizumab: Phase II data

BioCentury | Jul 18, 2011
Clinical News

Teplizumab: Additional Phase II/III data

BioCentury | Oct 25, 2010
Clinical News

Teplizumab: Phase II/III data

BioCentury | Apr 29, 2010
Finance

Beta testing in diabetes

BioCentury | Jan 11, 2010
Emerging Company Profile

Tolera: Delta Force Improves Tolerance

BioCentury | Jun 22, 2009
Clinical News

Teplizumab: Completed Phase II/III enrollment

BioCentury | Jun 22, 2009
Clinical News

Teplizumab: Phase III started

BioCentury | Aug 6, 2007
Clinical News

Teplizumab: Phase II/III ongoing

BioCentury | Jan 8, 2007
Clinical News

Teplizumab: Phase II/III started

Items per page:
1 - 10 of 13